Index trend and stocks in action on March 06, 2020
Index trend and stocks in action on March 06, 2020

Index trend and stocks in action on March 06, 2020

Karan Dsij Article rating: 5.0

If Nifty closes below 11,244, which is Thursday’s low, it will be an indication of the continuation of downtrend. However, a close below 11,000 level will have severe repercussions on the market. Stocks in news: Dr Reddy’s Laboratories, SBI, HCC, Lemon Tree, Pidilite Industries, Ester Industries, Agro Tech Foods.

Airtel partners with TCS for its HOBS PPM solution
Airtel partners with TCS for its HOBS PPM solution

Airtel partners with TCS for its HOBS PPM solution

Rishikesh Gaikwad Article rating: 4.6

Tata Consultancy Services (TCS) has successfully implemented TCS HOBS Product Portfolio Management (PPM) solution for Airtel. This will accelerate Airtel's digital transformation journey.

Zydus Cadila gets approval for liver disease drug
Zydus Cadila gets approval for liver disease drug

Zydus Cadila gets approval for liver disease drug

Pratik Shastri Article rating: 4.3

The company had filed an application for the abovementioned drug in December 2019. This has now become the first globally indicated drug for the treatment of NASH. Otherwise, there was no treatment available for this progressive liver disease.

Granules surge post USFDA nod for Potassium Chloride tablets
Granules surge post USFDA nod for Potassium Chloride tablets

Granules surge post USFDA nod for Potassium Chloride tablets

Apurva Joshi Article rating: 3.5

US Food & Drug Administration (USFDA) has approved Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc (GPI), a wholly-owned foreign subsidiary of Granules India Limited for Potassium Chloride Extended-Release Tablets USP, 8 mEq (600 mg) and 10 mEq (750 mg).

Rupee strengthens against US Dollar by 14 paise
Rupee strengthens against US Dollar by 14 paise

Rupee strengthens against US Dollar by 14 paise

Apurva Joshi Article rating: 5.0

Indian rupee gained against US dollar on Thursday, followed by firm domestic equities tracking global peers that gained on the back of former US Vice President Biden's big win, central banks' rate cut and World Bank's $12 billion aid package.

Andhra Bank reacts positively on stake hike by GoI
Andhra Bank reacts positively on stake hike by GoI

Andhra Bank reacts positively on stake hike by GoI

Pratik Shastri Article rating: 3.9

In terms of stock returns, PSU banks have performed very poorly, despite a consistent capital infusion by the government. Set of 18 PSU banking stocks has declined as much as 49 per cent since January 2019 till date.

Alembic Pharma gets USFDA nod for Doxycycline Hyclate tablets
Alembic Pharma gets USFDA nod for Doxycycline Hyclate tablets

Alembic Pharma gets USFDA nod for Doxycycline Hyclate tablets

Apurva Joshi Article rating: 5.0

Alembic Pharmaceuticals Limited has received final approval from US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Doxycycline Hyclate Tablets USP, 20 mg.

Deepak Nitrite invests 20 per cent stake in DOIL
Deepak Nitrite invests 20 per cent stake in DOIL

Deepak Nitrite invests 20 per cent stake in DOIL

Apurva Joshi Article rating: 4.1

Deepak Nitrite Limited has informed the bourses about investing around 20 per cent stake in Deepak Oman Industries FZC LLC (DOIL), a Limited Liability Company (LLC) incorporated in Sultanate of Oman amounting to an investment of approximately USD 7.71 million, in one or more tranches.

Allcargo surges post SEBI nod to acquire stake in Gati
Allcargo surges post SEBI nod to acquire stake in Gati

Allcargo surges post SEBI nod to acquire stake in Gati

Amir Shaikh Article rating: 4.2

Allcargo Logistics on Wednesday informed the bourses that it has received the approval from SEBI on its open offer to acquire additional nearly 3.17 crore shares in Gati 

RSS
First28722873287428752877287928802881Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR